Radiotherapy & Oncology
Volume 88, Issue 3 , Pages 289-309, September 2008

A literature review of electronic portal imaging for radiotherapy dosimetry

  • Wouter van Elmpt

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Wouter van Elmpt, Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, Dr. Tanslaan 12, NL-6229 ET Maastricht, The Netherlands.
    • Both authors contributed equally to this work.
  • ,
  • Leah McDermott

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    • Both authors contributed equally to this work.
  • ,
  • Sebastiaan Nijsten

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, The Netherlands
  • ,
  • Markus Wendling

      Affiliations

    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
  • ,
  • Philippe Lambin

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, The Netherlands
  • ,
  • Ben Mijnheer

      Affiliations

    • Department of Radiation Oncology (MAASTRO), GROW, University Hospital Maastricht, The Netherlands
    • Department of Radiation Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

Received 9 April 2008; received in revised form 9 July 2008; accepted 12 July 2008. published online 15 August 2008.

Abstract 

Electronic portal imaging devices (EPIDs) have been the preferred tools for verification of patient positioning for radiotherapy in recent decades. Since EPID images contain dose information, many groups have investigated their use for radiotherapy dose measurement. With the introduction of the amorphous-silicon EPIDs, the interest in EPID dosimetry has been accelerated because of the favourable characteristics such as fast image acquisition, high resolution, digital format, and potential for in vivo measurements and 3D dose verification. As a result, the number of publications dealing with EPID dosimetry has increased considerably over the past ∼15 years. The purpose of this paper was to review the information provided in these publications. Information available in the literature included dosimetric characteristics and calibration procedures of various types of EPIDs, strategies to use EPIDs for dose verification, clinical approaches to EPID dosimetry, ranging from point dose to full 3D dose distribution verification, and current clinical experience. Quality control of a linear accelerator, pre-treatment dose verification and in vivo dosimetry using EPIDs are now routinely used in a growing number of clinics. The use of EPIDs for dosimetry purposes has matured and is now a reliable and accurate dose verification method that can be used in a large number of situations. Methods to integrate 3D in vivo dosimetry and image-guided radiotherapy (IGRT) procedures, such as the use of kV or MV cone-beam CT, are under development. It has been shown that EPID dosimetry can play an integral role in the total chain of verification procedures that are implemented in a radiotherapy department. It provides a safety net for simple to advanced treatments, as well as a full account of the dose delivered. Despite these favourable characteristics and the vast range of publications on the subject, there is still a lack of commercially available solutions for EPID dosimetry. As strategies evolve and commercial products become available, EPID dosimetry has the potential to become an accurate and efficient means of large-scale patient-specific IMRT dose verification for any radiotherapy department.

Keywords: EPID dosimetry, Pre-treatment dose verification, In vivo dosimetry, IMRT verification, Portal dosimetry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(08)00372-1

doi:10.1016/j.radonc.2008.07.008

Radiotherapy & Oncology
Volume 88, Issue 3 , Pages 289-309, September 2008